Clinical Trials Browser

Interventional × Solid Tumors × 90 days × Clear all

NCT07395258 2026-06-04

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Suspended

Other solid neoplasm

Solid Tumors

NCT07624864 2026-06-03

A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT04303858 2026-06-02

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumors

NCT03448042 2026-05-28

A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07152236 2026-05-28

Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors

Phase NA Withdrawn

Other solid neoplasm

Solid Tumors

NCT07538479 2026-05-28

NIVALIS

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07591155 2026-05-28

A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT04250155 2026-05-26

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07176975 2026-05-26

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT07181681 2026-05-26

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT05839600 2026-05-22

A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

Phase 1 Terminated

10 enrolled 12 charts

Other solid neoplasm

Solid Tumors

NCT07602855 2026-05-22

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT05155332 2026-05-20

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

Phase 1 Suspended

Other solid neoplasm

Solid Tumors

NCT06066424 2026-05-15

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07415031 2026-05-15

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07583953 2026-05-13

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT02320435 2026-05-12

A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial

Phase 3 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT00777582 2026-05-08

Phase I Comparative Bioavailability Study

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT04589845 2026-05-08

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Phase 2 Active not recruiting

920 enrolled 1 FDA

Other solid neoplasm

Solid Tumors

NCT06885281 2026-05-08

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06761417 2026-05-07

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06926751 2026-05-07

Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06651593 2026-05-06

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06227377 2026-04-27

QTX3034 in Patients With KRAS G12D Mutation

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06816992 2026-04-24

ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC

Phase 1 Recruiting

Other solid neoplasmThoracic

Solid Tumors

NCT04123366 2026-04-22

MK-7339-007

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT06892379 2026-04-20

A Study of HS-20110 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT04174716 2026-04-17

VASTUS

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06082960 2026-04-16

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT05203172 2026-04-07

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Phase 4 Recruiting

Other solid neoplasm

Solid Tumors

NCT03917381 2026-04-06

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07505069 2026-04-01

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06873789 2026-03-25

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT07032077 2026-03-20

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT02789228 2026-03-19

REST

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT05101070 2026-03-18

aCCeleR8-001

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors